Abstract:Several drugs of aziridinylbenzoquinone analogs have undergone clinical trials as potential antitumor drugs. These bioreductive compounds are designed to kill tumor cells preferentially within the hypoxic microenvironment. From our previous reported data, it was round that the synthesized 2-aziridin-1-yl-3-[(2-{2-[(3-aziridin-1,4-dioxo-1,4-dihydronaphthalen-2-yl)thio]ethoxy}ethyl)thio]naphthoquinone (AZ-1) is a bioreductive compound with potent lethal effect on oral cancer cell, OEC-M1. It was found in this study that the lethal effect of the oral cancer cell lines OEC-M1 induced by AZ-1 wits mediated through the cell cycle arrest and apoptosis pathway.The LC50 Values of OEC-M1 and KB cells induced by AZ-1 compound were 0.72 and 1.02 mu M, respectively, which were much lower than that of normal fibroblast cells (SF with LC50 = 5.6 mu M) with more than 90% of normal fibroblasts surviving as compared to control at a concentration of AZ-1 as high as 2 mu M. It was interesting to note that the LC50 of monotype diaziridinylbenzoquinone compound, diaziquone (AZQ), was 50 mu M on OEC-M1 cells. Comparing the cytotoxicity of AZ-1 and AZQ on OEC-M1 cells, AZ-1 is approximately 70 times more potent than AZQ.By using Western blot, both G(2)/M phase cell cycle arresting protein, cyclin B, and anti-apoptotic protein, bel-2, were expressed in OEC-M1 cell when the concentrations or AZ-1 were increased from 0.125 to 0.5 mu M and then decreased from 1o 2 mu M of AZ-1 treatment as compared with control for 24 h. Both proteins were expressed most abundantly at 0.5 mu M AZ-1. However, the expression of bel-2 protein in OEC-M1 was significantly decreasing in a dose-dependent manner and was only about 50% protein level at 2 mu M AZ-1 for 48 h as compared with control. The cell survival check protein p53 increased from 1.72- to 2.8-fold and 1.36- to 2.16 fold at concentrations of AZ-1 from 0.125 to 2.0 mu M in it dose-dependently increasing manner on OEG-M1 as compared with control For 24 and 48 h treatments, respectively. The apoptotic-related phenomena were observed, which included apoptotic body formation and the enzyme activity change of caspase-3. The apoptotic bodies and caspase-3 activity of OEC-M1 were induced only at 2 mu M AZ-1 for a 24 h treatment, yet apoptotic body formation was observed at as low as 0.5 mu M AZ-1 and in a dose-dependently increasing manner for a 48 h treatment. The caspasc-3 activity was increased 20%, 26.8%, and 84.2%,, respectively, at 0.5, 1, and 2 mu M concentrations of AZ-1 for a 48 h treatment as compared with control. These results indicate that AZ-1 induced the cell death of OEG-M1 through the G(2)/M phase arrest of cell cycle and anti-apoptosis first and then apoptosis following a 48 h treatment. All of the pathway might be associated with bel-2 and p53 protein expression. We propose that the AZ-1 could be used its anti-oral cancer drug for future studies with animal models. (c) 2005 Elsevier Ltd. All rights reserved.

A Novel 7‐azaisoindigo Derivative‐induced Cancer Cell Apoptosis and Mitochondrial Dysfunction Mediated by Oxidative Stress

The Inhibitory Effect and Possible Mechanism of a Novel 7-azaisoindigo on Proliferation of A549 Cells

The Antitumor Effect of a Novel 7-azaisoindigo in vitro and in vivo

7-b, a novel amonafide analogue, cause growth inhibition and apoptosis in Raji cells via a ROS-mediated mitochondrial pathway.

A novel topoisomerase I inhibitor DIA-001 induces DNA damage mediated cell cycle arrest and apoptosis in cancer cell.

III-10, a Newly Synthesized Flavonoid, Induces Cell Apoptosis with the Involvement of Reactive Oxygen Species-Mitochondria Pathway in Human Hepatocellular Carcinoma Cells.

Synthesis and Antitumor Activity of a New 7-Azaindole Derivative

A Novel Imidazopyridine Derivative Exerts Anticancer Activity by Inducing Mitochondrial Pathway-Mediated Apoptosis.

A ROS-mediated Lysosomal–mitochondrial Pathway is Induced by a Novel Amonafide Analogue, 7c, in Human Hela Cervix Carcinoma Cells

Novel NO-releasing scopoletin derivatives induce cell death via mitochondrial apoptosis pathway and cell cycle arrest

An Isoquinolin-1(2H)-Imine Derivative Induces Cell Death Via Generation of Reactive Oxygen Species and Activation of JNK in Human A549 Cancer Cells.

B7 Induces Apoptosis in Colorectal Cancer Cells by Regulating the Expression of Caspase-3 and Inhibits Autophagy.

Both DNA Damage and Mitochondrial Dysfunction Are Involved in Novel Oxadiazolo[3,4‐d]pyrimidine Nucleoside Derivatives‐induced Cancer Cell Death

Oxazine drug-seed induces paraptosis and apoptosis through reactive oxygen species/JNK pathway in human breast cancer cells

The Lethal Effect of Bis-Type Azridinylnaphthoquinone Derivative on Oral Cancer Cells (OEC-M1) Associated with Anti-Apoptotic Protein Bcl-2.

7-Acetylsinumaximol B Induces Apoptosis and Autophagy in Human Gastric Carcinoma Cells through Mitochondria Dysfunction and Activation of the PERK/eIF2α/ATF4/CHOP Signaling Pathway

Novel Small Molecules As Apoptosis Inducers: Synthesis, Preliminary Structure-Activity Relationships, And In Vitro Biological Evaluation

Identification And Biological Evaluation Of Novel Benzothiazole Derivatives Bearing A Pyridine-Semicarbazone Moiety As Apoptosis Inducers Via Activation Of Procaspase-3 To Caspase-3

Novel camphor-based pyrimidine derivatives induced cancer cell death through a ROS-mediated mitochondrial apoptosis pathway

(3,19)‐4‐Bromobenzylidene‐isoandrographolide Induces Apoptosis and Causes Loss of Mitochondrial Membrane Potential in MCF‐7 Breast Cancer Cells

Anthracenedione Derivative 1403P-3 Induces Apoptosis in KB and KBv200 Cells Via Reactive Oxygen Species-Independent Mitochondrial Pathway and Death Receptor Pathway